Search

Your search keyword '"Fujishiro, Noriko"' showing total 13 results
Start Over Author "Fujishiro, Noriko"
13 results on '"Fujishiro, Noriko"'

1. Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential

Author

Suzuki, Nao, Takai, Yasushi, Yonemura, Masahito, Negoro, Hiromitsu, Motonaga, Shinya, Fujishiro, Noriko, Nakamura, Eishin, Takae, Seido, Yoshida, Saori, Uesugi, Koji, Ohira, Takashi, Katsura, Aiko, Fujiwara, Michio, Horiguchi, Itsuko, Kosaki, Kenjiro, Onodera, Hiroshi, and Nishiyama, Hiroyuki

Published
2022
Full Text
View/download PDF

3. Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer

Author

Masuishi, Toshiki, Taniguchi, Hiroya, Kotani, Daisuke, Bando, Hideaki, Komatsu, Yoshito, Shinozaki, Eiji, Nakajima, Takako Eguchi, Satoh, Taroh, Nishina, Tomohiro, Esaki, Taito, Wakabayashi, Masashi, Nomura, Shogo, Takahashi, Koji, Ono, Hiromi, Hirano, Nami, Fujishiro, Noriko, Fuse, Nozomu, Sato, Akihiro, Ohtsu, Atsushi, and Yoshino, Takayuki

Published
2019
Full Text
View/download PDF

5. A Survey of Experience and Perception of Bereaved Families about Polypharmacy and Oral Medication of Patients with Advanced Cancer

Author

Abe, Kentaro, primary, Miura, Tomofumi, additional, Fujishiro, Noriko, additional, Okizaki, Ayumi, additional, Yoshino, Naoko, additional, Aoki, Shigeru, additional, Naito, Akemi, additional, Mano, Yasunari, additional, Saito, Shinichiro, additional, Yamaguchi, Masakazu, additional, and Morita, Tatsuya, additional

Published
2021
Full Text
View/download PDF

6. A basket trial of trastuzumab deruxtecan, a HER2-targeted antibody-drug conjugate, for HER2-amplified solid tumors identified by circulating tumor DNA analysis (HERALD trial).

Author

Yagisawa, Masataka, primary, Nakamura, Yoshiaki, additional, Yoshino, Takayuki, additional, Komatsu, Yoshito, additional, Kadowaki, Shigenori, additional, Muro, Kei, additional, Sunakawa, Yu, additional, Satoh, Taroh, additional, Nishina, Tomohiro, additional, Esaki, Taito, additional, Fujii, Satoshi, additional, Ono, Hiromi, additional, Tomita, Daiki, additional, Fujishiro, Noriko, additional, Hirano, Nami, additional, Fuse, Nozomu, additional, Sato, Akihiro, additional, Ogawa, Gakuto, additional, Nomura, Shogo, additional, and Taniguchi, Hiroya, additional

Published
2020
Full Text
View/download PDF

7. An open-label phase II study of lenvatinib plus pembrolizumab in patients with advanced gastric cancer (EPOC1706).

Author

Kawazoe, Akihito, primary, Fukuoka, Shota, additional, Nakamura, Yoshiaki, additional, Kuboki, Yasutoshi, additional, Mikamoto, Yuichi, additional, Shima, Hikari, additional, Fujishiro, Noriko, additional, Higuchi, Tsukiko, additional, Wakabayashi, Masashi, additional, Nomura, Shogo, additional, Sato, Akihiro, additional, and Shitara, Kohei, additional

Published
2020
Full Text
View/download PDF

9. Frequency of severe neutropenia occurring as an adverse events of gemcitabine plus cisplatin chemotherapy in patients with recurrent biliary tract cancer compared to those with unresectable biliary tract cancer.

Author

Fujishiro, Noriko, primary, Mitsunaga, Shuichi, additional, Shinohara, Akira, additional, Takeno, Misaki K, additional, Funazaki, Hideki, additional, Kimura, Gen, additional, Watanabe, Kazuo, additional, Umemoto, Kumiko, additional, Sasaki, Mitsuhito, additional, Takahashi, Hideaki, additional, Imaoka, Hiroshi, additional, Hashimoto, Yusuke, additional, Ohno, Izumi, additional, and Ikeda, Masafumi, additional

Published
2017
Full Text
View/download PDF

10. The Effect of Brimonidine on Intraocular Pressure via the Central Nervous System in the Conscious Pigmented Rabbit

Author

SODA, Mitsutaka, primary, YOSHIDA, Masato, additional, ONDA, Hidetoshi, additional, Guo, SHI-YU, additional, NAKANISHI-UEDA, Takako, additional, UEDA, Toshihiko, additional, FUJISHIRO, Noriko, additional, HISAMITSU, Tadashi, additional, INATOMI, Makoto, additional, YASUHARA, Hajime, additional, OGUCHI, Katsuji, additional, and KOIDE, Ryohei, additional

Published
2003
Full Text
View/download PDF

13. [International Comparison of Clinical Information Related to Contraception of Medicines].

Author

Yonemura M, Fujishiro N, and Motonaga S

Subjects
Europe, Female, Humans, Japan, Male, Time Factors, United States, Contraception, Pharmaceutical Preparations
Abstract

Most of the warnings about the contraceptive period when using medicines are described as"fixed period"in the package insert, and it is necessary for healthcare professionals to provide information on the specific contraceptive period when using medicines that require contraception. There are many situations where we have trouble. Furthermore, the presence or absence of a description that requires contraception and the contraceptive period differ even though the drugs are the same in Japan and overseas. For example, paclitaxel injection(albumin suspension type)in the package insert in Japan, an appropriate contraceptive period for a certain period have been given to female and male are required. In contrast, different warnings of contraception have been given to female and male another in Europe for 1 month and 6 months after administration, and in the United States for 6 months and for 3 months. The description of the contraceptive period in the package insert in Japan needs to be described after clearly stating the specific period, and it is necessary to describe detailed information including the contraceptive method in materials such as interview forms.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results